Effect of long-term laboratory propagation on Chlamydia trachomatis genome dynamics

Infection, Genetics and Evolution

Volumn 17, Issue , 2013, Pages 23-32

  Borges, Vítor ^a   Ferreira, Rita ^a   Nunes, Alexandra ^a   Sousa Uva, Mafalda ^b   Abreu, Miguel ^c   Borrego, Maria J ^a   Gomes, João P ^a  

^a NATIONAL INSTITUTE OF HEALTH DR RICARDO JORGE   (Portugal)

^b UNIVERSIDADE NOVA DE LISBOA   (Portugal)

^c INSTITUTO SUPERIOR TÉCNICO   (Portugal)

Author keywords

Adaptation; Chlamydia trachomatis; Evolution; In vitro propagation; Mutation; Selective advantage

Indexed keywords

ARTICLE; BACTERIAL GENOME; BACTERIAL GROWTH; BACTERIAL REPRODUCTION; BACTERIAL STRAIN; BACTERIUM ISOLATE; CHLAMYDIA TRACHOMATIS; CONTROLLED STUDY; DNA SEQUENCE; EVOLUTIONARY ADAPTATION; GENE LOCATION; GENE SEQUENCE; GENOME ANALYSIS; HUMAN; HUMAN CELL; IN VITRO STUDY; MATHEMATICAL COMPUTING; MATHEMATICAL MODEL; MOLECULAR CLONING; MUTATION RATE; MUTATIONAL ANALYSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; REPRODUCTIVE FITNESS; TRANSCRIPTION REGULATION;

CELL LINE; CHLAMYDIA TRACHOMATIS; GENETIC FITNESS; GENOME, BACTERIAL; GENOMIC INSTABILITY; HUMANS; MODELS, STATISTICAL; MUTATION; MUTATION RATE;

BACTERIA (MICROORGANISMS); CHLAMYDIA TRACHOMATIS;

EID: 84876718480     PISSN: 15671348     EISSN: 15677257     Source Type: Journal    
DOI: 10.1016/j.meegid.2013.03.035     Document Type: Article

References (68)

1. Andersson D.I., Hughes D. Muller's ratchet decreases fitness of a DNA-based microbe. Proc. Natl. Acad. Sci. U.S.A. 1996, 93:906-907.
2. Barrick J.E., Yu D.S., Yoon S.H., Jeong H., Oh T.K., Schneider D., Lenski R.E., Kim J.F. Genome evolution and adaptation in a long-term experiment with Escherichia coli. Nature 2009, 461:1243-1247.
3. Belland R.J., Scidmore M.A., Crane D.D., Hogan D.M., Whitmire W., McClarty G., Caldwell H.D. Chlamydia trachomatis cytotoxicity associated with complete and partial cytotoxin genes. Proc. Natl. Acad. Sci. U.S.A. 2001, 98:13984-13989.
4. Binet R., Maurelli A.T. Frequency of spontaneous mutations that confer antibiotic resistance in Chlamydia spp. Antimicrob. Agents Chemother. 2005, 49:2865-2873.
5. Biškup U.G., Strle F., Ružić-Sabljić E. Loss of plasmids of Borrelia burgdorferi sensu lato during prolonged in vitro cultivation. Plasmid 2011, 66:1-6.
6. Borges V., Ferreira R., Nunes A., Nogueira P., Borrego M.J., Gomes J.P. Normalization strategies for real-time expression data in Chlamydia trachomatis. J. Microbiol. Methods 2010, 82:256-264.
7. Borges V., Nunes A., Ferreira R., Borrego M.J., Gomes J.P. Directional evolution of Chlamydia trachomatis towards niche-specific adaptation. J. Bacteriol. 2012, 194:6143-6153.
8. Bush R.M., Smith C.B., Cox N.J., Fitch W.M. Effects of passage history and sampling bias on phylogenetic reconstruction of human influenza A evolution. Proc. Natl. Acad. Sci. U.S.A. 2000, 97:6974-6980.
9. Caldwell H.D., Kromhout J., Schachter J. Purification and partial characterization of the major outer membrane protein of Chlamydia trachomatis. Infect. Immun. 1981, 31:1161-1176.
10. Carlson J.H., Porcella S.F., McClarty G., Caldwell H.D. Comparative genomic analysis of Chlamydia trachomatis oculotropic and genitotropic strains. Infect. Immun. 2005, 73:6407-6418.
11. Carlson J.H., Whitmire W.M., Crane D.D., Wicke L., Virtaneva K., Sturdevant D.E., Kupko J.J., Porcella S.F., Martinez-Orengo N., Heinzen R.A., Kari L., Caldwell H.D. The Chlamydia trachomatis plasmid is a transcriptional regulator of chromosomal genes and a virulence factor. Infect. Immun. 2008, 76:2273-2283.
12. Catry M.A., Borrego M.J., Cardoso J., Azevedo J., Santo I. Comparison of the Amplicor Chlamydia trachomatis test and cell culture for the detection of urogenital chlamydial infections. Genitourin. Med. 1995, 71:247-250.
13. Conrad T.M., Lewis N.E., Palsson B.Ø. Microbial laboratory evolution in the era of genome-scale science. Mol. Syst. Biol. 2011, 7:509.
14. Cooper T.F., Rozen D.E., Lenski R.E. Parallel changes in gene expression after 20,000 generations of evolution in Escherichia coli. Proc. Natl. Acad. Sci. U.S.A. 2003, 100:1072-1077.
15. Derré I., Swiss R., Agaisse H. The lipid transfer protein CERT interacts with the Chlamydia inclusion protein IncD and participates to ER-Chlamydia inclusion membrane contact sites. PLoS Pathog. 2011, 7:e1002092.
16. Dettman J.R., Rodrigue N., Melnyk A.H., Wong A., Bailey S.F., Kassen R. Evolutionary insight from whole-genome sequencing of experimentally evolved microbes. Mol. Ecol. 2012, 21:2058-2077.
17. Drake J.W., Charlesworth B., Charlesworth D., Crow J.F. Rates of spontaneous mutation. Genetics 1998, 148:1667-1686.
18. Elena S.F., Lenski R.E. Evolution experiments with microorganisms: the dynamics and genetic bases of adaptation. Nat. Rev. Genet. 2003, 4:457-469.
19. Farencena A., Comanducci M., Donati M., Ratti G., Cevenini R. Characterization of a new isolate of Chlamydia trachomatis which lacks the common plasmid and has properties of biovar trachoma. Infect. Immun. 1997, 65:2965-2969.
20. Felsenstein J. The evolutionary advantage of recombination. Genetics 1974, 78:737-756.
21. Fong S.S., Joyce A.R., Palsson B.Ø. Parallel adaptive evolution cultures of Escherichia coli lead to convergent growth phenotypes with different gene expression states. Genome Res. 2005, 15:1365-1372.
22. Gerrish P.J., Lenski R.E. The fate of competing beneficial mutations in an asexual population. Genetica 1998, 102-103:127-144.
23. Gomes J.P. Genomic stability of genotyping markers in Chlamydia trachomatis. Front. Cell. Infect. Microbiol. 2012, 2:77.
24. Gomes J.P., Borrego M.J., Atik B., Santo I., Azevedo J., Brito de Sá A., Nogueira P., Dean D. Correlating Chlamydia trachomatis infectious load with urogenital ecological success and disease pathogenesis. Microbes Infect. 2006, 8:16-26.
25. Herring C.D., Raghunathan A., Honisch C., Patel T., Applebee M.K., Joyce A.R., Albert T.J., Blattner F.R., van den Boom D., Cantor C.R., Palsson B.Ø. Comparative genome sequencing of Escherichia coli allows observation of bacterial evolution on a laboratory timescale. Nat. Genet. 2006, 38:1406-1412.
26. Iliopoulos I., Tsoka S., Andrade M.A., Enright A.J., Carroll M., Poullet P., Promponas V., Liakopoulos T., Palaios G., Pasquier C., Hamodrakas S., Tamames J., Yagnik A.T., Tramontano A., Devos D., Blaschke C., Valencia A., Brett D., Martin D., Leroy C., Rigoutsos I., Sander C., Ouzounis C.A. Evaluation of annotation strategies using an entire genome sequence. Bioinformatics 2003, 19:717-726.
27. Kari L., Goheen M.M., Randall L.B., Taylor L.D., Carlson J.H., Whitmire W.M., Virok D., Rajaram K., Endresz V., McClarty G., Nelson D.E., Caldwell H.D. Generation of targeted Chlamydia trachomatis null mutants. Proc. Natl. Acad. Sci. U.S.A. 2011, 108:7189-7193.
28. Kersh G.J., Oliver L.D., Self J.S., Fitzpatrick K.A., Massung R.F. Virulence of pathogenic Coxiella burnetii strains after growth in the absence of host cells. Vector Borne Zoonotic Dis. 2011, 11:1433-1438.
29. Kutlin A., Kohlhoff S., Roblin P., Hammerschlag M.R., Riska P. Emergence of resistance to rifampin and rifalazil in Chlamydophila pneumoniae and Chlamydia trachomatis. Antimicrob. Agents Chemother. 2005, 49:903-907.
30. Labiran C., Clarke I.N., Cutcliffe L.T., Wang Y., Skilton R.J., Persson K., Bjartling C., Herrmann B., Christerson L., Marsh P. Genotyping markers used for multi locus VNTR analysis with ompA (MLVA-ompA) and multi sequence typing retain stability in Chlamydia trachomatis. Front. Cell. Infect. Microbiol. 2012, 2:68.
31. Lambden P.R., Pickett M.A., Clarke I.N. The effect of penicillin on Chlamydia trachomatis DNA replication. Microbiology 2006, 152:2573-2578.
32. Lee D.H., Palsson B.Ø. Adaptive evolution of Escherichia coli K-12 MG1655 during growth on a Nonnative carbon source, L-1,2-propanediol. Appl. Environ. Microbiol. 2010, 76:4158-4168.
33. Lefebvre J.F., Orfila J. Polypeptidic composition analysis of "Chlamydia" purified elementary bodies by polyacrylamide slab gel electrophoresis (author's transl). Ann. Microbiol. (Paris) 1980, 131B:223-237.
34. Martínez M.A., Verdaguer N., Mateu M.G., Domingo E. Evolution subverting essentiality: dispensability of the cell attachment Arg-Gly-Asp motif in multiply passaged foot-and-mouth disease virus. Proc. Natl. Acad. Sci. U.S.A. 1997, 94:6798-6802.
35. Mathews S.A., Volp K.M., Timms P. Development of a quantitative gene expression assay for Chlamydia trachomatis identified temporal expression of sigma factors. FEBS Lett. 1999, 458:354-358.
36. Meyer Y., Buchanan B.B., Vignols F., Reichheld J.P. Thioredoxins and glutaredoxins: unifying elements in redox biology. Annu. Rev. Genet. 2009, 43:335-367.
37. Mishra M.K., Gerard H., Whittum-Hudson J., Hudson A., Kannan R.M. Dendrimer-enabled modulation of gene expression in Chlamydia trachomatis. Mol. Pharm. 2012, 9:413-421.
38. Miyairi I., Mahdi O.S., Ouellette S.P., Belland R.J., Byrne G.I. Different growth rates of Chlamydia trachomatis biovars reflect pathotype. J. Infect. Dis. 2006, 194:350-357.
39. Muller H.J. The relation of recombination to mutational advance. Mutat. Res. 1964, 106:2-9.
40. Nguyen B.D., Valdivia R.H. Virulence determinants in the obligate intracellular pathogen Chlamydia trachomatis revealed by forward genetic approaches. Proc. Natl. Acad. Sci. U.S.A. 2012, 109:1263-1268.
41. O'Connell C.M., Nicks K.M. A plasmid-cured Chlamydia muridarum strain displays altered plaque morphology and reduced infectivity in cell culture. Microbiology 2006, 152:1601-1607.
42. Omsland A., Cockrell D.C., Howe D., Fischer E.R., Virtaneva K., Sturdevant D.E., Porcella S.F., Heinzen R.A. Host cell-free growth of the Q fever bacterium Coxiella burnetii. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:4430-4434.
43. Omsland A., Sager J., Nair V., Sturdevant D.E., Hackstadt T. Developmental stage-specific metabolic and transcriptional activity of Chlamydia trachomatis in an axenic medium. Proc. Natl. Acad. Sci. U.S.A. 2012, 109:19781-19785.
44. Paterson S., Vogwill T., Buckling A., Benmayor R., Spiers A.J., Thomson N.R., Quail M., Smith F., Walker D., Libberton B., Fenton A., Hall N., Brockhurst M.A. Antagonistic coevolution accelerates molecular evolution. Nature 2010, 464:275-278.
45. Peterson E.M., Markoff B.A., Schachter J., de la Maza L.M. The 7.5-kb plasmid present in Chlamydia trachomatis is not essential for the growth of this microorganism. Plasmid 1990, 23:144-148.
46. Ramsey K.H., Sigar I.M., Schripsema J.H., Denman C.J., Bowlin A.K., Myers G.A., Rank R.G. Strain and virulence diversity in the mouse pathogen Chlamydia muridarum. Infect. Immun. 2009, 77:3284-3293.
47. Rupp J., Solbach W., Gieffers J. Variation in the mutation frequency determining quinolone resistance in Chlamydia trachomatis serovars L2 and D. J. Antimicrob. Chemother. 2008, 61:91-94.
48. Russell M., Darville T., Chandra-Kuntal K., Smith B., Andrews C.W., O'Connell C.M. Infectivity acts as in vivo selection for maintenance of the chlamydial cryptic plasmid. Infect. Immun. 2011, 79:98-107.
49. Sandoz K.M., Eriksen S.G., Jeffrey B.M., Suchland R.J., Putman T.E., Hruby D.E., Jordan R., Rockey D.D. Resistance to a novel antichlamydial compound is mediated through mutations in Chlamydia trachomatis secY. Antimicrob. Agents Chemother. 2012, 56:4296-4302.
50. Schachter J., Meyer K.F. Lymphogranuloma venereum II. Characterization of some recently isolated strains. J. Bacteriol. 1969, 99:636-638.
51. Shaw E.I., Dooley C.A., Fischer E.R., Scidmore M.A., Fields K.A., Hackstadt T. Three temporal classes of gene expression during the Chlamydia trachomatis developmental cycle. Mol. Microbiol. 2000, 37:913-925.
52. Sniegowski P.D., Gerrish P.J., Johnson T., Shaver A. The evolution of mutation rates: separating causes from consequences. Bioessays 2000, 22:1057-1066.
53. Song L., Carlson J.H., Whitmire W.M., Kari L., Virtaneva K., Sturdevant D.E., Watkins H., Zhou B., Sturdevant G.L., Porcella S.F., McClarty G., Caldwell H.D. Chlamydia trachomatis plasmid-encoded Pgp4 is a transcriptional regulator of virulence-associated genes. Infect. Immun. 2013, 81:636-644.
54. Stephens R.S., Kalman S., Lammel C., Fan J., Marathe R., Aravind L., Mitchell W., Olinger L., Tatusov R.L., Zhao Q., Koonin E.V., Davis R.W. Genome sequence of an obligate intracellular pathogen of humans: Chlamydia trachomatis. Science 1998, 282:754-759.
55. Stoebel D.M., Hokamp K., Last M.S., Dorman C.J. Compensatory evolution of gene regulation in response to stress by Escherichia coli lacking RpoS. PLoS Genet. 2009, 5:e1000671.
56. Stothard D.R., Van Der Pol B., Smith N.J., Jones R.B. Effect of serial passage in tissue culture on sequence of omp1 from Chlamydia trachomatis clinical isolates. J. Clin. Microbiol. 1998, 36:3686-3688.
57. Sturdevant G.L., Kari L., Gardner D.J., Olivares-Zavaleta N., Randall L.B., Whitmire W.M., Carlson J.H., Goheen M.M., Selleck E.M., Martens C., Caldwell H.D. Frameshift mutations in a single novel virulence factor alter the in vivo pathogenicity of Chlamydia trachomatis for the female murine genital tract. Infect. Immun. 2010, 78:3660-3668.
58. Subtil A., Delevoye C., Balañá M.E., Tastevin L., Perrinet S., Dautry-Varsat A. A directed screen for chlamydial proteins secreted by a type III mechanism identifies a translocated protein and numerous other new candidates. Mol. Microbiol. 2005, 56:1636-1647.
59. Suchland R.J., Bourillon A., Denamur E., Stamm W.E., Rothstein D.M. Rifampin-resistant RNA polymerase mutants of Chlamydia trachomatis remain susceptible to the ansamycin rifalazil. Antimicrob. Agents Chemother. 2005, 49:1120-1126.
60. Suchland R.J., Jeffrey B.M., Xia M., Bhatia A., Chu H.G., Rockey D.D., Stamm W.E. Identification of concomitant infection with Chlamydia trachomatis IncA-negative mutant and wild-type strains by genomic, transcriptional, and biological characterizations. Infect. Immun. 2008, 76:5438-5446.
61. Sullivan N., Sun Y., Sattentau Q., Thali M., Wu D., Denisova G., Gershoni J., Robinson J., Moore J., Sodroski J. CD4-Induced conformational changes in the human immunodeficiency virus type 1 gp120 glycoprotein: consequences for virus entry and neutralization. J. Virol. 1998, 72:4694-4703.
62. Tang F.F., Chang H.L., Huang Y.T., Wang K.C. Studies on the etiology of trachoma with special reference to isolation of the virus in chick embryo. Chin. Med. J. 1957, 75:429-447.
63. Taubenberger J.K., Reid A.H., Lourens R.M., Wang R., Jin G., Fanning T.G. Characterization of the 1918 influenza virus polymerase genes. Nature 2005, 437:889-893.
64. Thomson N.R., Holden M.T., Carder C., Lennard N., Lockey S.J., Marsh P., Skipp P., O'Connor C.D., Goodhead I., Norbertzcak H., Harris B., Ormond D., Rance R., Quail M.A., Parkhill J., Stephens R.S., Clarke I.N. Chlamydia trachomatis: genome sequence analysis of lymphogranuloma venereum isolates. Genome Res. 2008, 18:161-171.
65. Vannucci F.A., Foster D.N., Gebhart C.J. Comparative transcriptional analysis of homologous pathogenic and non-pathogenic Lawsonia intracellularis isolates in infected porcine cells. PLoS One 2012, 7:e46708.
66. Van Valen L. A new evolutionary law. Evol. Theory 1973, 1:1-30.
67. Wang Y., Kahane S., Cutcliffe L.T., Skilton R.J., Lambden P.R., Clarke I.N. Development of a transformation system for Chlamydia trachomatis: restoration of glycogen biosynthesis by acquisition of a plasmid shuttle vector. PLoS Pathog. 2011, 7:e1002258.
68. Zeyl C. The number of mutations selected during adaptation in a laboratory population of Saccharomyces cerevisiae. Genetics 2005, 169:1825-1831.